SEBI examines Sun Pharma, Ranbaxy merger trading: Srcs
The Securities and Exchange Board of India (Sebi) is likely to issue notice to Sun Pharma and Ranbaxy over insider trading allegations following the merger pact between the two, say sources.
Other Corporate Videos
TCS screening candidates for C-suite rejig ahead; COO, CTO posts to be filled soon
Unicorn ed-tech firm Byju's lays off at least 1,000 more employees across various functions
Tata Trusts appoints Siddharth Sharma as CEO, Aparna Uppaluri as COO
Government to release standards for checking fake reviews on e-commerce, other platforms
Reliance retail, Adani group companies among bidders for Future Retail
